26 results
8-K
EX-99.2
HRMY
Harmony Biosciences Holdings, Inc.
6 Aug 24
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-dose Program Toward Expected Pdufa Date In 2028
8:15am
EPX-200 (Lorcaserin) Developmental and Epileptic Encephalopathies (DEE) Sleep/Wake Neurobehavioral Rare Epilepsy
7 Strengthening Our Leadership … fatigue as a symptom and a lower general QoL.6 Patients reported residual symptoms on medications5
8 Strengthening Our Leadership Position in Sleep
8-K
EX-99.1
HRMY
Harmony Biosciences Holdings, Inc.
30 Apr 24
WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year
7:45am
FRANCHISE TO EXTEND REVENUE POTENTIAL BEYOND 2040; STRENGHTENS SLEEP/WAKE LEADERSHIP AND DIVERSIFIES INTO RARE EPILEPSY
WAKIX® (pitolisant) Net Revenue … Formulations; Reports Positive Pharmacokinetic Data on Next-Generation Formulation 1 (NG1); PDUFA Expected in 2026
Strengthens Leadership Position in Sleep
8-K
EX-99.2
HRMY
Harmony Biosciences Holdings, Inc.
30 Apr 24
WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year
7:45am
the franchise revenue growth potential beyond 2040 ▪ NG1 – PDUFA date in 2026 ▪ NG2 – On track for PK data in 1H 2024 ▪ Strengthens leadership position with TPM
8-K
EX-99.1
qdcs4ud 43w
8 Nov 23
Harmony Biosciences Appoints
8:30am
8-K
EX-99.1
9zgmsmtki
27 Jul 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-99.1
vf4jatxf qo3
24 Apr 23
Harmony Biosciences Announces Jeffrey M. Dayno, M.D. Appointed President & Chief Executive Officer
8:30am
8-K
3f1g8bsgp jk6
24 Apr 23
Harmony Biosciences Announces Jeffrey M. Dayno, M.D. Appointed President & Chief Executive Officer
8:30am
DEF 14A
6fhiie
9 Apr 21
Definitive proxy
6:05am
10-K
777n a1h8
25 Mar 21
Annual report
8:17am
8-K
EX-99.1
t1dbvhkfbwpjqmpyv
15 Mar 21
Harmony Biosciences Appoints Sandip Kapadia As Chief Financial Officer
8:05am
10-Q
y4p 1c4812dte2fu8
12 Nov 20
Quarterly report
8:15am
8-K
EX-99.1
76qkw 05q2x2ouxa
12 Nov 20
Harmony Biosciences Appoints Mark Graf and Eric Motley
6:07am
424B4
wz9 fijmy
20 Aug 20
Prospectus supplement with pricing info
12:00am